Skip to main content

Bank of New York Mellon Corp

Bank

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$591,387,145
+$1,491,683 QoQ
Shares Held
765,411
+0.2% QoQ
Ownership
0.730%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 90.72929445748754.ToString("F0")% Shared 0.1177145350667811.ToString("F0")% None 9.152991007445673.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,202,987,460 across 269 Biotechnology names. REGN ranks #2 (14.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
765,411 $591,387,145

All Filings in REGN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $591,387,145 765,411
2025-12-31 $589,895,462 764,242
2025-09-30 $377,637,391 671,630
2025-06-30 $344,727,600 656,624
2025-03-31 $442,852,991 698,253
2024-12-31 $490,982,706 689,263
2024-09-30 $751,716,485 715,076
2024-06-30 $908,344,260 864,242
2024-03-31 $853,289,723 886,544
2023-12-31 $833,123,926 948,575
2023-09-30 $796,143,016 967,414
2023-06-30 $693,210,018 964,748
2023-03-31 $816,713,676 993,968
2022-12-31 $710,286,696 984,472
2022-09-30 $704,523,873 1,022,724
2022-06-30 $566,218,002 957,857
2022-03-31 $640,491,641 917,058
2021-12-31 $558,277,566 884,022
2021-09-30 $533,051,616 880,815
2021-06-30 $479,571,375 858,616
2021-03-31 $400,294,413 846,038
2020-09-30 $459,090,123 820,126
2020-06-30 $482,175,617 773,151
2020-03-31 $299,107,893 612,562